Elevated donor hemoglobin A1c does not impair early survival in cardiac transplant recipients.
Jeremy T JosephMichael S MulvihillBabatunde A YerokunSadé M BellCarmelo A MilanoMatthew G HartwigPublished in: Clinical transplantation (2017)
No difference in four-year survival was noted in recipients who received allografts from hyperglycemic donors. These results suggest that recent cumulative donor glycemic status alone may not be an important predictor of recipient outcomes.